Drug:
Reaction: DEATH
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26555311 |
ZA |
59 | 1 |
Death, |
||||
DARBEPOETIN ALFA, |
||||
| 2 | 26555331 |
US |
68 | 2 |
Death, |
||||
RISANKIZUMAB-RZAA, |
||||
| 3 | 26555342 |
CH |
85 | 1 |
Death, |
||||
| 4 | 26555424 |
US |
43 | 2 |
Death, |
||||
TOFERSEN, |
||||
| 5 | 26555439 |
CA |
85 | |
Death, Productive cough, Sputum discoloured, Intentional dose omission, |
||||
INFLIXIMAB-DYYB, |
||||
| 6 | 26555440 |
EU |
70 | 2 |
Death, |
||||
ADALIMUMAB, |
||||
| 7 | 26555444 |
CA |
1 | |
Death, |
||||
UPADACITINIB, |
||||
| 8 | 26555478 |
CL |
2 | |
Death, |
||||
| 9 | 26555547 |
US |
57 | 2 |
Death, |
||||
CAPIVASERTIB, |
||||
| 10 | 26555661 |
GB |
1 | |
Death, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 11 | 26555689 |
CA |
84 | 2 |
Death, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 12 | 26555700 |
US |
83 | 2 |
Death, |
||||
LEVOTHYROXINE SODIUM, |
||||
| 13 | 26555754 |
US |
||
Death, |
||||
TIRZEPATIDE, |
||||
| 14 | 26555765 |
CA |
71 | 1 |
Death, |
||||
| 15 | 26555831 |
EU |
2 | |
Death, |
||||
POMALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ISATUXIMAB, |
||||
| 16 | 26555834 |
EU |
2 | |
Death, |
||||
POMALIDOMIDE, ISATUXIMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 17 | 26555876 |
AU |
||
Death, |
||||
DENOSUMAB, |
||||
| 18 | 26555968 |
CA |
75 | 2 |
Death, |
||||
FULVESTRANT, |
||||
| 19 | 26555972 |
US |
79 | 2 |
Death, |
||||
DOSTARLIMAB, |
||||
| 20 | 26555983 |
US |
69 | 1 |
Death, Balance disorder, |
||||
EDARAVONE, EDARAVONE, |
||||
| 21 | 26556031 |
SG |
72 | 2 |
Death, Dyspnoea, Pneumonia, |
||||
PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, |
||||
| 22 | 26556050 |
IN |
69 | 2 |
Death, |
||||
| 23 | 26556155 |
EU |
62 | |
Death, Ependymoma, Off label use, |
||||
BEVACIZUMAB, BEVACIZUMAB, TEMOZOLOMIDE, |
||||
| 24 | 26556303 |
EU |
||
Death, |
||||
AXICABTAGENE CILOLEUCEL, |
||||
| 25 | 26556365 |
US |
74 | 1 |
Death, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, |
||||
| 26 | 26556395 |
EU |
2 | |
Death, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 27 | 26556429 |
GB |
93 | 2 |
Death, |
||||
ETANERCEPT, |
||||
| 28 | 26556463 |
CA |
47 | |
Death, Hypoaesthesia, Mobility decreased, Myalgia, Headache, |
||||
AMBRISENTAN, AMBRISENTAN, TADALAFIL, |
||||
| 29 | 26556464 |
CA |
2 | |
Death, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 30 | 26556465 |
US |
1 | |
Death, |
||||
EPOETIN ALFA, |
||||
| 31 | 26556488 |
EU |
1 | |
Death, |
||||
POMALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ISATUXIMAB, |
||||
| 32 | 26556544 |
JP |
1 | |
Death, |
||||
ONABOTULINUMTOXINA, |
||||
| 33 | 26556569 |
US |
1 | |
Death, |
||||
DURVALUMAB, |
||||
| 34 | 26556602 |
US |
79 | 2 |
Death, |
||||
VONOPRAZAN FUMARATE, RIVAROXABAN, ACETAMINOPHEN, CYCLOSPORINE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, MUPIROCIN CALCIUM, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, FUROSEMIDE, TELMISARTAN, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ERGOCALCIFEROL, ALPRAZOLAM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 35 | 26556628 |
US |
60 | 1 |
Death, |
||||
RIFAXIMIN, |
||||
| 36 | 26556634 |
CN |
1 | |
Death, Nausea, Pallor, Tremor, Disease recurrence, Decreased appetite, Fatigue, Nasopharyngitis, Metastases to liver, Pulmonary mass, Neoplasm progression, General physical health deterioration, Gait disturbance, Somnolence, Confusional state, |
||||
TRASTUZUMAB, TRASTUZUMAB, OXALIPLATIN, OXALIPLATIN, CAPECITABINE, CAPECITABINE, |
||||
| 37 | 26556636 |
JM |
1 | |
Death, |
||||
NILOTINIB, |
||||
| 38 | 26556716 |
GB |
1 | |
Death, |
||||
LANREOTIDE ACETATE, |
||||
| 39 | 26556845 |
US |
92 | 1 |
Death, |
||||
DUPILUMAB, |
||||
| 40 | 26556866 |
CN |
1 | |
Death, |
||||
| 41 | 26556867 |
HK |
1 | |
Death, |
||||
| 42 | 26556929 |
CA |
1 | |
Death, |
||||
UPADACITINIB, |
||||
| 43 | 26557260 |
JP |
46 | 2 |
Death, Malaise, Hypertension, Palmar-plantar erythrodysaesthesia syndrome, Therapy partial responder, Malignant neoplasm progression, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, |
||||
| 44 | 26557276 |
US |
1 | |
Death, |
||||
SARGRAMOSTIM, |
||||
| 45 | 26557353 |
US |
1 | |
Death, |
||||
FENTANYL, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, MORPHINE, |
||||
| 46 | 26557384 |
IN |
69 | 1 |
Death, |
||||
DURVALUMAB, |
||||
| 47 | 26557486 |
CN |
1 | |
Myelosuppression, Decreased appetite, Asthenia, Liver injury, Death, |
||||
TRASTUZUMAB, CISPLATIN, CAPECITABINE, |
||||
| 48 | 26557491 |
US |
76 | |
Death, |
||||
LOTILANER OPHTHALMIC SOLUTION, LOTILANER OPHTHALMIC SOLUTION, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, IRON, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, PANCRELIPASE, |
||||
| 49 | 26557716 |
US |
77 | |
Death, |
||||
AMLODIPINE BESYLATE, DOXEPIN HYDROCHLORIDE, DOXEPN HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, PREDNISOLONE ACETATE, FAMOTIDINE, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE GEL USP, 1%, CLINDAMYCIN PHOSPHATE TOPICAL, |
||||
| 50 | 26557899 |
US |
70 | 1 |
Death, |
||||
RIFAXIMIN, |
||||
| 51 | 26557900 |
CA |
56 | |
Death, |
||||
RIFAXIMIN, |
||||
| 52 | 26557909 |
US |
77 | 2 |
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 53 | 26557916 |
EU |
66 | 2 |
Death, Breast cancer, Malignant neoplasm progression, Lung disorder, Metastases to bone, Pleural effusion, Pleural disorder, Disease progression, Computerised tomogram abnormal, |
||||
RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, |
||||
| 54 | 26557921 |
CO |
64 | 1 |
Death, Perforation, Rash, |
||||
PANITUMUMAB, |
||||
| 55 | 26557993 |
US |
98 | 2 |
Death, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 56 | 26557995 |
US |
90 | 1 |
Death, |
||||
FARICIMAB, |
||||
| 57 | 26558049 |
|||
Death, |
||||
AMIKACIN, |
||||
| 58 | 26558053 |
US |
2 | |
Death, |
||||
BRENSOCATIB, AMLODIPINE, LISINOPRIL, CEFUROXIME, LATANOPROST, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 59 | 26558114 |
CO |
1 | |
Death, Colon cancer, Weight decreased, Gait disturbance, Fatigue, |
||||
MEPOLIZUMAB, |
||||
| 60 | 26558126 |
EU |
2 | |
Death, |
||||
| 61 | 26558317 |
US |
1 | |
Death, Malaise, Weight decreased, Increased appetite, |
||||
TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, |
||||
| 62 | 26558343 |
US |
82 | |
Death, |
||||
| 63 | 26558462 |
US |
62 | 1 |
Death, |
||||
RIFAXIMIN, |
||||
| 64 | 26558539 |
US |
70 | 1 |
Death, |
||||
RAVULIZUMAB, |
||||
| 65 | 26558604 |
US |
83 | 2 |
Death, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 66 | 26558714 |
US |
||
Death, |
||||
VELPATASVIR AND SOFOSBUVIR, |
||||
| 67 | 26558730 |
US |
72 | 2 |
Death, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, |
||||
| 68 | 26558771 |
US |
79 | 1 |
Death, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 69 | 26558879 |
EU |
37 | 1 |
Death, |
||||
PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, METHADONE, |
||||
| 70 | 26558999 |
HK |
1 | |
Death, |
||||
| 71 | 26559003 |
HK |
1 | |
Death, |
||||
| 72 | 26559096 |
GB |
||
Death, Cytokine release syndrome, General physical health deterioration, Rash, Nausea, |
||||
TEBENTAFUSP, |
||||
| 73 | 26559119 |
CO |
60 | 2 |
Death, |
||||
VENETOCLAX, |
||||
| 74 | 26559129 |
US |
34 | 2 |
Death, |
||||
VENETOCLAX, REVUMENIB, |
||||
| 75 | 26559136 |
CA |
1 | |
Death, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, PREDNISONE, ESOMEPRAZOLE MAGNESIUM, GABAPENTIN, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, FUROSEMIDE, LORAZEPAM, ERGOCALCIFEROL, VITAMIN E, VITAMIN C, CALCIUM, FERROUS SULFATE, FISH OIL, |
||||
| 76 | 26559137 |
US |
2 | |
Death, No adverse event, |
||||
| 77 | 26559228 |
CA |
||
Death, Intentional product use issue, |
||||
USTEKINUMAB, |
||||
| 78 | 26559279 |
PR |
74 | 2 |
Death, |
||||
CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, |
||||
| 79 | 26559298 |
US |
83 | 1 |
Death, Parkinson^s disease, Urinary retention, Constipation, Fatigue, Blood pressure decreased, |
||||
TAFAMIDIS, TAFAMIDIS, TAFAMIDIS, |
||||
| 80 | 26559313 |
US |
||
Death, Abdominal pain upper, |
||||
SELINEXOR, ACYCLOVIR, CARVEDILOL, NIFEDIPINE, PROCHLORPERAZINE, MORPHINE, ALLOPURINOL, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 81 | 26559316 |
EU |
85 | 1 |
Death, Intentional product use issue, Off label use, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, EMICIZUMAB, |
||||
| 82 | 26559342 |
EU |
||
Death, |
||||
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, |
||||
| 83 | 26559353 |
US |
||
Death, |
||||
VUTRISIRAN, |
||||
| 84 | 26559355 |
CA |
86 | |
Death, Unevaluable event, |
||||
VUTRISIRAN, VUTRISIRAN, |
||||
| 85 | 26559421 |
EU |
||
Death, |
||||
CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), ATEZOLIZUMAB, |
||||
| 86 | 26559443 |
EU |
80 | 2 |
Death, Hypoalbuminaemia, Drug ineffective, |
||||
RITUXIMAB, POLATUZUMAB VEDOTIN, GLOFITAMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISONE, BENDAMUSTINE HCL, OXALIPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, |
||||
| 87 | 26559460 |
IN |
||
Death, |
||||
RUXOLITINIB, |
||||
| 88 | 26559488 |
JP |
1 | |
Death, Wrong technique in product usage process, |
||||
BEMPEDOIC ACID, |
||||
| 89 | 26559489 |
CA |
19 | 2 |
Death, Joint dislocation, Shoulder fracture, Inappropriate schedule of product administration, |
||||
FLUOXETINE HYDROCHLORIDE, FLUOXETINE, QUETIAPINE, BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, |
||||
| 90 | 26559589 |
US |
68 | 2 |
Pneumonia bacterial, Acute respiratory failure, Acute kidney injury, Hyperkalaemia, Hypoalbuminaemia, Haemorrhage, Pulseless electrical activity, Septic shock, Cardiogenic shock, Arrhythmia, Right ventricular failure, Cardiac failure acute, Influenza, Interstitial lung disease, Pulmonary hypertension, Death, Product use issue, Incorrect dose administered, Acidosis, Hyperglycaemia, Weight decreased, |
||||
SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, DULOXETINE HYDROCHLORIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, CYANOCOBALAMIN, PANTOPRAZOLE SODIUM, INSULIN ASPART, MACITENTAN, EPOPROSTENOL, ATORVASTATIN CALCIUM, EZETIMIBE, LATANOPROST, PREDNISONE, SPIRONOLACTONE, OXYGEN, 0XYGEN, PRAMIPEXOLE DIHYDROCHLORIDE, DIGOXIN, MIDODRINE HYDROCHLORIDE, DAPAGLIFLOZIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, TORSEMIDE, BIMATOPROST, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, |
||||
| 91 | 26559646 |
EU |
74 | 1 |
Death, |
||||
TADALAFIL, |
||||
| 92 | 26559705 |
MA |
2 | |
Death, |
||||
PALBOCICLIB, |
||||
| 93 | 26559844 |
GB |
2 | 1 |
Death, Metastases to lung, Hallucination, Neurotoxicity, Constipation, Anxiety, Poor quality sleep, Allodynia, Disturbance in attention, Somnolence, Decreased appetite, Inadequate analgesia, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, CELECOXIB, CLONIDINE, CLONIDINE, CLONIDINE, CLONAZEPAM, CLONAZEPAM, BUPIVACAINE, BUPIVACAINE HYDROCHLORIDE IN DEXTROSE, DOXORUBICIN, IFOSFAMIDE, TRABECTEDIN, |
||||
| 94 | 26559850 |
US |
85 | |
Death, |
||||
NIVOLUMAB, IPILIMUMAB, |
||||
| 95 | 26559921 |
EU |
78 | 1 |
Death, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 96 | 26559932 |
EU |
||
Death, |
||||
| 97 | 26559938 |
SG |
63 | 2 |
Death, |
||||
ADO-TRASTUZUMAB EMTANSINE, |
||||
| 98 | 26559995 |
EU |
||
Death, |
||||
CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), ATEZOLIZUMAB, |
||||
| 99 | 26560018 |
US |
71 | 1 |
Death, |
||||
| 100 | 26560028 |
CA |
60 | 2 |
Death, |
||||
OSIMERTINIB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28